Literature DB >> 11817661

Molecular mechanisms of atopy.

P J Barnes1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11817661      PMCID： PMC1781729          DOI： 10.1080/09629350120102000

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN： 0962-9351            Impact factor:   4.711


× No keyword cloud information.
  45 in total

Review 1.  Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both.

Authors:  K Kohno; M Kurimoto
Journal:  Clin Immunol Immunopathol       Date:  1998-01

2.  The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects.

Authors:  J V Fahy; H E Fleming; H H Wong; J T Liu; J Q Su; J Reimann; R B Fick; H A Boushey
Journal:  Am J Respir Crit Care Med       Date:  1997-06       Impact factor: 21.405

Review 3.  IL-10: a potential therapy for allergic inflammation?

Authors:  M Pretolani; M Goldman
Journal:  Immunol Today       Date:  1997-06

4.  An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.

Authors:  T S Kim; R H DeKruyff; R Rupper; H T Maecker; S Levy; D T Umetsu
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

5.  Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma.

Authors:  A J Van Oosterhout; C L Hofstra; R Shields; B Chan; I Van Ark; P M Jardieu; F P Nijkamp
Journal:  Am J Respir Cell Mol Biol       Date:  1997-09       Impact factor: 6.914

6.  Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial.

Authors:  L C Borish; H S Nelson; M J Lanz; L Claussen; J B Whitmore; J M Agosti; L Garrison
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

7.  Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone.

Authors:  M A Saunders; J A Mitchell; P M Seldon; M H Yacoub; P J Barnes; M A Giembycz; M G Belvisi
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

8.  Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma.

Authors:  M Humbert; S R Durham; P Kimmitt; N Powell; B Assoufi; R Pfister; G Menz; A B Kay; C J Corrigan
Journal:  J Allergy Clin Immunol       Date:  1997-05       Impact factor: 10.793

9.  Interleukin-10 regulation in normal subjects and patients with asthma.

Authors:  L Borish; A Aarons; J Rumbyrt; P Cvietusa; J Negri; S Wenzel
Journal:  J Allergy Clin Immunol       Date:  1996-06       Impact factor: 10.793

10.  Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.

Authors:  C Zuany-Amorim; S Hailé; D Leduc; C Dumarey; M Huerre; B B Vargaftig; M Pretolani
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.